Regencell Bioscience Holdings Limited Net Change in Cash
Regencell Bioscience Holdings Limited (RGC) reported Net Change in Cash of -$542.12 thousand for the 12-month period ending 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-10-31
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|
| 2025-06-30 | -$542.12K 20-F · filed 2025-10-31 |
| 2024-06-30 | $1.40M 20-F · filed 2025-10-31 |
| 2023-06-30 | -$4.85M 20-F · filed 2025-10-31 |
| 2022-06-30 | $6.36M 20-F · filed 2024-10-25 |
| 2021-06-30 | -$327.57K 20-F · filed 2023-10-27 |